SEATTLE, April 14, 2021, (MEDGADGET) — Blood coagulation tube is a blood collection tube that consists of the highly viscous gel-like form known as clot either it prevents the clotting of blood or accelerates blood clotting. A tube that has a clot activator produces a serum sample when the blood is separated by centrifugation whereas a tube that contains an anticoagulant produces a plasma sample after centrifugation. Some tests are done by using serum, some plasma, and other tests require anti-coagulated whole blood.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/139
Coagulation tests primarily measure the body plasma’s ability to clot as well as time taken for the same. Coagulation testing helps doctors assess the risk of extreme bleeding or developing thrombosis inside blood vessels. Moreover, these tests are useful for detecting several proteins and their functions. Conditions that can cause clotting disorders include liver disease, thrombophilia (excessive clotting), and hemophilia (inability to clot normally). Moreover, coagulation tests are also carried out before certain surgeries depending on the history and condition of the patient.
Blood coagulation tubes primarily contain a solution of tri-sodium citrate. The citrate concentrations are available in two varieties namely0.129 mol/l (3.8%) and0.109 mol/l (3.2%). The mixing ratio is usually one portion citrate to nine portions of blood. These tubes also contain adenosine, theophilline, and dipyridamole.
Blood Coagulation Tubes Taxonomy
Based on citrate concentration
- 8% citrate solution
- 2% citrate solution
Based on the type of end-user
- Diagnostic Centers
- Medical Practitioners
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/139
The global blood coagulation tubes market is projected to grow at a substantial rate over the forecast period (2016–2024) and this can be attributed to growing health awareness among the global population along with the rising prevalence of low platelet count or thrombocytopenia, liver diseases, and rise in number of surgeries are factor that argue well for growth of the market.
Growing prevalence of thrombosis and liver diseases a major driver for the growth of global blood coagulation tubes market
According to the American Liver Foundation, in 2013, around 30 million people in the U.S.—a whopping 10% of the population—suffered from some form of liver disease. Liver disease is also considered to be the ‘fifth big killer’ in England and Wales, in 2013, as per the WHO-HFA database. Blood coagulation tubes are widely used for diagnosing thrombosis. According to the Center for Disease Control and Prevention (CDC), as many as 900,000 people in the U.S. suffer from thrombosis each year. Fibrinogen activity is tested to evaluate bleeding disorders. They are used to diagnose diseases such as disseminated intravascular coagulation. As per the Department of Medicine, the University of Alabama at Birmingham, in South Asia, especially in India, the fibrinogen levels are usually high, owing to high occurrences of coronary heart diseases and higher levels of wound-induced glycoprotein IIb/IIIa that acts as a receptor for fibrinogen. This, in turn, will result in increased blood coagulation tests in this region. A report by the Journal of Thrombosis and Hemostasis, emphasizes the need for controlled and randomized assessments with clinical result measurement to establish that thromboprophylaxis (prevention of thromboembolic disease or obstruction of blood vessels by a blood clot) is essential in joint surgery in Asia. Since blood coagulation tests are usually suggested before and after surgery, growth in a number of surgeries is also expected to provide major growth traction to the blood coagulation tubes market. As per independent estimates, around 232 million surgeries are performed worldwide each year. Europe and North America are the highest revenue contributors to the global blood clotting tubes market. This is mainly attributed to robust healthcare infrastructure and easy access to advanced healthcare facilities in these regions. However, Asia Pacific is expected to emerge as a high growth region in the global blood coagulation market, owing to an increase in the adoption of blood coagulation tests and a high prevalence of heart attack and stroke, along with the rising incidence of thrombosis and chronic liver diseases in the region.
Some of the major competitors operating in the blood coagulation tubes industry are Medical Expo, Ajosha BioTeklik Pvt. Ltd., CML Biotech Pvt. Ltd., New MicroMed International Pvt. Ltd., Greiner BioOne, Gosselin, FL Medical, and Advacare Pharma.
Product launches and continuous innovations by key market players are expected to facilitate the growth of the blood coagulation tubes market. For instance, in August 2019, medical device company Q-Sera Pty Ltd. announced that its Q-Sera technology, a blood clotting technology to be used in blood collection tubes, has been granted a patent in the U.S. by the United States Patent & Trademark Office.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027